Cardiac arrest can run in families, and the link is stronger than many people realize. A long-running study of nearly 8,000 men found that having one parent who died of sudden cardiac death almost doubled a person’s own risk, and having both parents affected raised it roughly ninefold.1Radcliffe Cardiology (Arrhythmia & Electrophysiology Review). Genetics of Sudden Cardiac Death: Overview of Genetic Risk Factors and Aetiologies But “hereditary” does not mean “inevitable.” Some people carry a single gene variant that directly predisposes them to a fatal heart rhythm, while others inherit a cluster of risk factors that only becomes dangerous when combined with lifestyle or environmental triggers. Understanding which category applies to you or your family changes what screening and prevention look like.
How Family History Raises the Risk
The clearest evidence comes from large population studies that track families over time. In the Paris Prospective Study I, a parental history of sudden cardiac death was associated with a relative risk of 1.89, meaning roughly double the baseline risk. When both parents had suffered sudden cardiac death, the relative risk climbed to 9.44.1Radcliffe Cardiology (Arrhythmia & Electrophysiology Review). Genetics of Sudden Cardiac Death: Overview of Genetic Risk Factors and Aetiologies A separate case-control study in Seattle confirmed this pattern, showing that early-onset sudden cardiac death in a parent (before age 65) independently carried about a 2.7-fold increased risk even after accounting for a family history of heart attacks.
A study comparing heart attack patients who went into ventricular fibrillation with those who did not found that familial sudden death was present in about 43% of the cases versus 25% of controls, translating to an odds ratio of roughly 2.7.2PubMed. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients The finding held even though the overall prevalence of cardiovascular disease in family members was nearly identical between the two groups. In other words, it was not just heart disease that ran in families; it was the specific tendency toward dangerous heart rhythms.
A more recent analysis reinforced this, finding that a parental history of sudden cardiac arrest carried an adjusted odds ratio of about 2.5 for developing the condition yourself. That same study flagged several modifiable factors that piled on top of genetics: current smoking raised odds by about 40%, and not exercising regularly was associated with roughly a fourfold increase in risk.3Scientific Reports. Family history, socioeconomic factors, comorbidities, health behaviors, and the risk of sudden cardiac arrest This overlap between inherited risk and everyday habits is central to understanding cardiac arrest: genetics loads the gun, but lifestyle and environment often pull the trigger.
Inherited Heart Rhythm Disorders
Some of the most clearly hereditary causes of cardiac arrest are the so-called channelopathies, conditions where a genetic mutation disrupts the tiny ion channels that control the heart’s electrical activity. These are rare individually, but collectively they account for a meaningful share of sudden cardiac deaths in young, otherwise healthy people.
Long QT syndrome is the best studied. It is caused by mutations in genes that control potassium and sodium channels in heart cells, most commonly the KCNQ1, KCNH2, and SCN5A genes. A study of 647 genotyped patients from 193 families found that the risk of a first cardiac event before age 40, including fainting, cardiac arrest, or sudden death, varied depending on which gene was affected, the patient’s sex, and the length of the corrected QT interval on an electrocardiogram.4PubMed. Risk stratification in the long-QT syndrome This is one of the conditions where genetic testing directly changes management: someone with an LQT1 mutation might need to avoid strenuous swimming, while someone with LQT2 needs to be cautious about being startled awake by a loud alarm.
Brugada syndrome is another inherited arrhythmia condition that predisposes people to cardiac arrest, often during sleep. Despite being called an inherited syndrome, the genetics are more complex than a simple one-gene story. Most cases are not linked to a single identifiable gene variant.5JACC: Clinical Electrophysiology. Brugada Syndrome When SCN5A mutations are present, though, patients tend to have more severe disease, with a higher rate of the characteristic electrocardiographic pattern appearing on its own and a greater frequency of cardiac arrest or dangerous ventricular rhythms.6PubMed Central. Brugada syndrome genetics is associated with phenotype severity The condition has drawn particular attention in Southeast Asia, where sudden unexplained death during sleep in young men has been described for decades. A forensic study of 98 such cases in Thailand found SCN5A variants in about 5% of victims.7PubMed. SCN5A missense variants and their contribution to deaths in Sudden Unexplained Nocturnal Death Syndrome (SUNDS)
Catecholaminergic polymorphic ventricular tachycardia, or CPVT, is rarer still but dramatic in presentation. It causes dangerous heart rhythms specifically during exercise or intense emotional stress, and for some people, the first sign of the condition is cardiac arrest itself.8PubMed Central. Cardiac Arrest From Undiagnosed Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report Because resting heart tests often look completely normal, CPVT can go undiagnosed until a catastrophic event, making family history and genetic testing especially valuable.
Inherited Cardiomyopathies
While channelopathies disrupt the heart’s electrical wiring, inherited cardiomyopathies alter the heart muscle itself, and both pathways can lead to cardiac arrest. Hypertrophic cardiomyopathy is the most widely recognized of these. The heart muscle thickens abnormally, usually because of mutations in genes that encode structural proteins within the muscle cells. It is the most common cause of sudden death in young competitive athletes.9PubMed Central. Hypertrophic cardiomyopathy and sudden cardiac death A recent pediatric study quantified the genetic contribution directly: children with hypertrophic cardiomyopathy who carried specific sarcomere gene variants had about a tenfold higher odds of sudden cardiac arrest compared to those without such variants.10Heart Rhythm O2. Clinical manifestations, genetic profiles, and sudden cardiac arrest in pediatric hypertrophic cardiomyopathy: Challenges of risk prediction for initial sudden cardiac arrest presentations
Arrhythmogenic right ventricular cardiomyopathy, or ARVC, follows a different mechanism. Mutations in genes that code for desmosomal proteins, the molecular rivets holding heart muscle cells together, cause cells to detach and die. The lost muscle is gradually replaced by fatty and fibrous tissue, creating a substrate for dangerous arrhythmias.11PubMed Central. Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy Although classically described on the right side of the heart, both ventricles are often involved.12PubMed. Arrhythmogenic Cardiomyopathy Exercise can accelerate the disease, which is why competitive athletes with ARVC are typically advised to stop high-intensity training.
Dilated cardiomyopathy, where the heart chambers enlarge and the muscle weakens, can also be inherited. A meta-analysis covering more than 8,000 individuals with dilated cardiomyopathy found that certain gene mutations, particularly in the LMNA and PLN genes, carried a higher prevalence of sudden cardiac death, transplantation, or ventricular arrhythmias compared to mutations in the sarcomeric genes more commonly linked to hypertrophic cardiomyopathy.13PubMed. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals This matters because it means the specific mutation you carry, not just the general diagnosis, influences how aggressively doctors need to manage arrhythmia risk.
When Genetics Works Indirectly
Most cardiac arrests in the general population are not caused by rare channelopathies or cardiomyopathies. About 80% are linked to coronary artery disease: blocked arteries that starve the heart of blood and trigger chaotic rhythms. Coronary artery disease itself has a significant genetic component, meaning that genetics can set the stage for cardiac arrest even without a single dramatic mutation.
Familial hypercholesterolemia is a striking example. People with this inherited condition have extremely high levels of LDL cholesterol from birth, which accelerates plaque buildup in the arteries. Severe cases can present with advanced coronary artery disease even in adolescence.14PubMed Central. Familial hypercholesterolemia with early coronary atherosclerotic heart disease: A case report Over time, such blockages are what lead to heart attacks, and heart attacks are the most common immediate precursor to cardiac arrest.
Beyond single-gene conditions, researchers have constructed polygenic risk scores that combine the small effects of thousands of common gene variants to estimate your overall susceptibility to coronary artery disease and, by extension, to cardiac arrest. One study found a significant genetic correlation between coronary artery disease and sudden cardiac arrest, and showed that a polygenic risk score for coronary disease predicted sudden cardiac arrest risk with an odds ratio of about 1.16 per standard deviation increase in one cohort, and 1.09 in a second validation group.15medRxiv. A polygenic risk score to predict sudden cardiac arrest in patients with coronary artery disease Those numbers are modest at the individual level, but across a population they begin to identify people who could benefit from more aggressive prevention.
Triggers That Unmask Hidden Genetic Vulnerabilities
Carrying a genetic predisposition to a dangerous heart rhythm does not mean your heart is unstable every moment of the day. Many inherited arrhythmia syndromes stay silent for years until something tips the balance. The triggers vary by condition and include drugs, fever, electrolyte imbalances, and sudden shifts in heart rate.16Circulation Journal. Unveiling Specific Triggers and Precipitating Factors for Fatal Cardiac Events in Inherited Arrhythmia Syndromes
Fever is a particularly well-documented example in Brugada syndrome. A simple febrile illness can unmask the syndrome’s characteristic electrocardiographic pattern and provoke ventricular fibrillation in someone whose resting heart tracing had always looked normal.17PubMed Central. May fever trigger ventricular fibrillation? This has practical implications: if you know you carry a Brugada-related variant, treating fever promptly with antipyretics is not just about comfort; it may prevent a life-threatening arrhythmia. Knowing your genetic status turns a seemingly trivial clinical scenario into one that requires specific, informed action.
Exercise is the key trigger for CPVT and can worsen ARVC. Certain medications, particularly some antibiotics and psychiatric drugs that prolong the QT interval, can precipitate events in people with long QT syndrome. The interaction between genes and environment is why two siblings carrying the same mutation may have completely different outcomes: one might experience cardiac arrest in their twenties, while the other lives symptom-free into old age. Genetic risk is probabilistic, not deterministic.
What Happens After a Family Member Has a Cardiac Arrest
When someone in your family survives cardiac arrest or dies suddenly and unexpectedly, it raises urgent questions for relatives. Identifying whether an inherited condition was involved matters not just for understanding what happened, but for protecting living family members who may carry the same vulnerability.18PubMed Central. Clinical and genetic evaluation after sudden cardiac arrest
When no cause of death is found at autopsy, a “molecular autopsy” can be performed by analyzing the deceased person’s DNA for known arrhythmia and cardiomyopathy genes. For inherited arrhythmic diseases, the first symptom can be the fatal arrhythmia itself, which means the condition may be entirely invisible until it kills.19PubMed Central. Molecular autopsy in sudden cardiac death If a pathogenic variant is identified in the deceased, cascade screening of relatives becomes possible, testing each blood relative for the same variant and checking their hearts with imaging and electrocardiograms.
The yield of cascade screening is surprisingly high. A study focused on families of children who experienced sudden cardiac arrest found that among 155 relatives evaluated, 47% had a positive clinical evaluation and 41% carried a disease-causing mutation themselves.20PubMed Central. The role of genetic testing in the prevention, diagnosis, and prognosis of sudden cardiac arrest in children Those are not trivial numbers. Nearly half the tested family members were walking around with a condition that could have gone undiagnosed for years, and in some cases, the first sign would have been cardiac arrest.
Prevention When You Know Your Genetic Risk
Once an inherited arrhythmia or cardiomyopathy is diagnosed, prevention looks different depending on the specific condition and how severe it is. For people who have already survived cardiac arrest, an implantable cardioverter-defibrillator, or ICD, is generally recommended because the recurrence rate is high. The harder question is what to do for family members who carry the mutation but have never had an event.
A study comparing ICD outcomes across several inherited conditions found that the picture is not uniform. Patients with ARVC or hypertrophic cardiomyopathy who received ICDs for primary prevention had appropriate shock rates of roughly 4 to 7 per 100 patient-years, meaning the device delivered a lifesaving shock with some regularity. In contrast, primary prevention ICDs in patients with Brugada syndrome or long QT syndrome fired appropriately at rates approaching zero.21PubMed. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention Meanwhile, 35% of all patients experienced device-related complications. For conditions where the ICD rarely fires but complications are common, the risk-benefit calculation gets uncomfortable, especially in young people who will carry the device for decades.
Current guidelines reflect this uncertainty. There is broad agreement that ICDs make sense after a survived cardiac arrest, but the recommendation for primary prevention in people who have risk factors but no prior life-threatening event remains debated. Existing risk-prediction tools have a low positive predictive value, meaning many patients receive devices they will never need.22European Heart Journal. Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice? For some patients, lifestyle modifications, medication, and close follow-up may be a more appropriate first line of defense.
Genetic Testing Gaps and Disparities
Genetic testing for cardiac conditions has improved dramatically, but it is far from a perfect tool, and its accuracy is not equal across all populations. Most of the large genetic databases used to classify variants as harmful or harmless were built predominantly from people of European ancestry. This creates a real problem for everyone else.
A biobank study found that participants of African ancestry had more variants of uncertain significance in clinically important cardiac genes compared to those of European ancestry, even after adjusting for the total number of variants per person.23PubMed Central. Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants “Uncertain significance” is the genetic testing equivalent of a shrug: the lab cannot tell you whether the variant is dangerous or benign, which leaves patients and their doctors in limbo.
The consequences can be worse than uncertainty. A landmark analysis showed that multiple patients of African ancestry received reports classifying variants as pathogenic, meaning disease-causing, based on the evidence available at the time. Those variants were later reclassified as benign after better population data became available. In the interim, some of those patients may have undergone unnecessary procedures or lived with unfounded fear.24PubMed Central. Genetic Misdiagnoses and the Potential for Health Disparities The variants that were most commonly misclassified were significantly more frequent in Black Americans than in white Americans. As genetic databases grow more diverse, these errors should become less common, but the gap is not yet closed.
The Psychosocial Weight of Knowing
Receiving a genetic test result is not a purely medical event. Learning that you carry a mutation associated with sudden cardiac death can reshape your self-image, your relationships, and your daily decisions. A prospective study tracking people who underwent predictive genetic testing for hereditary heart diseases found that about 39% reported changes in their social, professional, or family life afterward. Most of those changes were viewed as positive, often because the result enabled concrete preventive steps or resolved years of uncertainty. Still, about 12% experienced changes they described as unfavorable, including anxiety, strained family dynamics, and workplace difficulties.25PubMed Central. Psychosocial Impact of Predictive Genetic Testing in Hereditary Heart Diseases: The PREDICT Study
The effect can ripple through families in complicated ways. A parent who tests positive may feel guilt about having passed a variant to a child. Siblings may disagree about whether to get tested at all. And a negative result in one family member does not always bring relief; it can create a strange survivor’s guilt within a family where others tested positive. Genetic counseling before and after testing helps people navigate these reactions, but the emotional dimension is worth taking seriously if you are considering testing for yourself or your family.
Emerging Tools for Detection and Treatment
Artificial intelligence is beginning to change how inherited arrhythmia syndromes are detected. Machine learning models trained on electrocardiograms have shown the ability to identify conditions like Brugada syndrome automatically, even from tracings that do not show the classic pattern to the human eye.26PubMed. A Deep Learning-Enabled Electrocardiogram Model for the Identification of a Rare Inherited Arrhythmia: Brugada Syndrome AI models have also shown promise in matching patients to specific genotypes and phenotypes, in some tasks outperforming expert cardiologists.27PubMed. Applying Artificial Intelligence for Phenotyping of Inherited Arrhythmia Syndromes If these tools reach routine clinical use, they could flag at-risk individuals from standard heart tracings done for unrelated reasons, turning a test millions of people already get into a screening opportunity for rare genetic conditions.
On the treatment side, gene therapy for monogenic cardiac diseases is an area of active research. Conditions caused by a single well-understood gene mutation are considered particularly good candidates because the molecular target is clear. Current treatments for many inherited arrhythmias and cardiomyopathies are limited and often poorly effective, which is part of what drives the urgency behind gene-therapy development.28Cardiovascular Research. Gene therapy for cardiac diseases: methods, challenges, and future directions Delivering genetic material specifically to heart cells, getting it to produce the right protein at the right level, and ensuring the effect lasts without triggering immune reactions are all hurdles that remain partially unsolved. But the trajectory is clear: for conditions where a single broken gene underlies a life-threatening disease, correcting or compensating for that gene at the source is the logical endpoint.